You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

 

Online download statistics by month:

Online download statistics by month: November 2018 to March 2024

AbstractFullPdf
Nov 201812112159
Dec 201811611628
Jan 2019656455
Feb 2019413879
Mar 2019504447
Apr 2019858554
May 2019454541
Jun 2019333341
Jul 2019343554
Aug 2019363477
Sep 2019474736
Oct 2019565657
Nov 2019353534
Dec 2019464549
Jan 2020464654
Feb 2020413954
Mar 2020464668
Apr 2020131327
May 2020363533
Jun 2020363626
Jul 2020343024
Aug 2020211914
Sep 2020483921
Oct 2020484323
Nov 2020312520
Dec 2020524826
Jan 2021433924
Feb 2021282619
Mar 2021544824
Apr 2021938517
May 202119117825
Jun 2021454123
Jul 2021464223
Aug 2021423620
Sep 2021322412
Oct 2021554429
Nov 2021221728
Dec 2021232118
Jan 2022272421
Feb 2022625219
Mar 2022726729
Apr 2022484216
May 2022504712
Jun 2022867314
Jul 2022645310
Aug 2022495522
Sep 2022817911
Oct 2022615415
Nov 2022695819
Dec 2022777013
Jan 2023827529
Feb 2023847819
Mar 2023707416
Apr 2023686319
May 2023615816
Jun 202365594
Jul 2023798018
Aug 2023929119
Sep 2023666810
Oct 2023867814
Nov 2023929020
Dec 2023827515
Jan 2024544515
Feb 2024807617
Mar 202411211019
Total385536121814